C001 Navigating Practice Management in Dermatology: Insights and Innovations
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This course will give participants increased perspective into a wide variety of topics applicable to practice management within dermatology. Key topics include coding and insurer updates, incorporating wellness, diversity and safety concepts into a practice, how to approach legislative updates affecting dermatology, and current barriers in accessing medications and how to approach them. Participants will also have the opportunity to pose their own practice management questions to the expert panel. This activity has been approved by the American Board of Dermatology (ABD) for up to 40 Continuing Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Appropriately utilize modifiers and updates in procedural coding, as well as recognize how insurers are approaching these topics.
Incorporate technological advancements into a practice to reduce administrative burden and develop best practices for managing staff.
Identify regulatory updates affecting the practice of dermatology, as well as how to prepare for them.
SCHEDULE
6:00 PM
Telemedicine
Elizabeth Jones, MD, FAAD
6:30 PM
AI and Patient Safety
James S. Taylor, MD, FAAD
7:00 PM
Quality Payment Program
Alina G. Bridges, DO, FAAD
7:30 PM
Incorporating Clinical Trials Into Practice
George Han, MD, PhD, FAAD
8:00 PM
Prior Authorization and Administrative Burdens
Drew Arthur Emge, MD, MSc, FAAD
8:30 PM
Coding
Christopher M DiMarco, MD, FAAD
9:00 PM
Coding - Updates and Interactive Session
Alexandra Flamm, MD, FAAD, Faith McNicholas
9:45 PM
Q&A
SPEAKERS
Alina G. Bridges, DO, FAAD
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Christopher M DiMarco, MD, FAAD
Brown Dermatology
Drew Arthur Emge, MD, MSc, FAAD
University of Kansas Physicians
Alexandra Flamm, MD, FAAD
George Han, MD, PhD, FAAD
Elizabeth Jones, MD, FAAD
Faith McNicholas
American Academy of Dermatology Association
James S. Taylor, MD, FAAD
Cleveland Clinic Foundation and Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
HANDOUTS
SPEAKER DISCLOSURES
Alina G. Bridges, DO, FAAD
No financial relationships exist with ineligible companies.
Christopher M DiMarco, MD, FAAD
No financial relationships exist with ineligible companies.
Drew Arthur Emge, MD, MSc, FAAD
No financial relationships exist with ineligible companies.
Alexandra Flamm, MD, FAAD
No financial relationships exist with ineligible companies.
George Han, MD, PhD, FAAD
AbbVie – Speaker(Honoraria); Amgen – Advisory Board(Honoraria); Avillion – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Advisory Board(Honoraria); Celgene – Investigator(Grants/Research Funding); DermTech Inc. – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Hikma Pharmaceuticals – Speaker/Faculty Education(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); MC2 Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Othro Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sonoma Pharmaceuticals – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); UCB – Advisory Board(Honoraria);
Elizabeth Jones, MD, FAAD
No financial relationships exist with ineligible companies.
Faith McNicholas
No financial relationships exist with ineligible companies.
James S. Taylor, MD, FAAD
AstraZeneca – Stockholder Public Company(Stock); Cigna – Stockholder Public Company(Stock); Johnson & Johnson Consumer Products Company – Stockholder Public Company(Stock); Kao Brands – Consultant (1099 relationship)(Grants/Research Funding); Merck & Co., Inc. – Stockholder Public Company(Stock); OPKO Health, Inc. – Stockholder Public Company(Stock); Organon & Co. – Stockholder Public Company(Stock); US Food and Drug Administration, Center for Devices and Radiological Health – Other(Honoraria);